Disseminated Gonococcal Infection Associated with Eculizumab Therapy for Paroxysmal Nocturnal Hemoglobinuria: A Case Report and Literature Review

Eculizumab has been developed as a breakthrough treatment for paroxysmal nocturnal hemoglobinuria (PNH). Not only for breakthroughs, eculizumab therapy is also known to increase the risk of invasive meningococcal infection. It has also been recently reported that, although rarely, administration of...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Makoto, Harada, Shinpei, Ogasawara, Reiki, Izumiyama, Koh, Mori, Akio, Morioka, Masanobu, Kondo, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372493/
https://www.ncbi.nlm.nih.gov/pubmed/32765045
http://dx.doi.org/10.2147/IJGM.S255298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372493/
https://www.ncbi.nlm.nih.gov/pubmed/32765045
http://dx.doi.org/10.2147/IJGM.S255298

Ejemplares similares